PharmaTalkRadio

Latest Episodes:

Connecting Employee-Centric Culture to Patient-Centric Culture Nov 01, 2019

Show notes

At the 2019 Patients as Partners EU meeting, Servier's Lode Dewulf presented a discussion on connecting employee-centric culture to patient-centric culture. This presentation covered the following points: • What impact can engaged employees have on positioning the company as the preferred partner for patients and other collaborators? • How can this be done? And for what purpose? • How do you engage your employees and empower them to implement patient involvement strategies? • Inspiring employees to make change? The 4th annual Patients as Partners EU conference will take place on January 27-28, 2020. To learn more about patient centricity in drug development and R&D and the Patients as Partners EU program, visit theconferenceforum.org.

Eliciting Patient Experience Data to Understand Medicines Benefits/Disadvantages Oct 31, 2019

Show notes

In this podcast, listen to a session from the 2019 Patients as Partners EU conference on Sanofi Eliciting Patient Experience Data During Clinical Trials to Better Understand Patient-Perceived Benefits and Disadvantages of their Drugs. Dr Aude Roborel de Climens, PRO/COA Lead at Sanofi discusses how they capture patient experiences during clinical research and the benefit of collecting direct patient feedback. More specifically, she presents how they evaluate and analyse qualitatively and quantitatively individual patient experiences of benefits and risks of drugs during clinical trials to better understand and support clinical results and help future design of patient support programs. The 4th annual Patients as Partners EU conference will take place on January 27-28, 2020 in London, UK. To learn more about patient centricity in R&D and the Patients as Partners EU program, visit theconferenceforum.org.

Understanding the Language of Patients - The Value of Health Literacy Oct 30, 2019

Show notes

In this podcast, hear a session presented at the 2019 Patients as Partners EU conference on the Process to Understand the Language of Patients and the Value of Health Literacy. Who is responsible for delivering the why and how of getting involved in medicines development? Pharma, regulators or advocacy groups?What practical goals can the industry set to effect change?How are we communicating the trial information to patients and care partners to help them understand and make informed decisions?How can we address the communication challenges faced by patients and care partners while navigating the systemConsiderations for language used in adverse events reporting, informed consent and clinical trial summaries Speaker: James (Jay) Duhig, PhD, Director, Patient Integration, Pharmacovigilance and Patient Safety (PPS), AbbVie The 4th annual Patients as Partners EU conference will take place on January 27-28, 2020 in London, UK. To learn more about the Patients as Partners EU program and patient centricity in R&D, visit theconferenceforum.org.

UCB and Parkinson's UK Collaboration Improve a Trial through Patient Involvement Oct 29, 2019

Show notes

In this podcast, hear a case study from the 2019 Patients as Partners EU conference on UCB and Parkinson's UK Working Together to Improve a Phase 2 Trial through Patient Involvement. In 2018, UCB and Parkinson’s UK co-developed a workshop to enable the UCB research team to work together with people affected by Parkinson’s to discuss and develop a potential phase 2 clinical trial. The aim of the workshop was to better understand people’s thoughts on clinical trials and get feedback on key features of the potential trial to maximise appropriateness, acceptability and success. In this session, attendees hear a multi-stakeholder perspective on the collaboration, including: • How the workshop was co-developed • Benefits and impact of patient involvement • Key challenges and solutions during the collaboration • Practical tips for industry and patient organisation collaborations Speakers: Natasha Ratcliffe, PhD, Research Involvement Manager, Parkinson’s UK Elaine Sutcliffe, Patient Advocate Kate Trenam, UK Patient Advocacy and Policy Manager, UCB The 4th annual Patients as Partners EU conference will take place on January 27-28, 2020 in London, UK. To learn more about patient centricity in R&D and the Patients as Partners EU program, visit theconferenceforum.org.

Improving T Cell Therapies via Next Generation Technologies Oct 17, 2019

Show notes

The pipeline of adoptive T-cell therapies and other cell based immuno-oncology programs continues to expand with a number of modifications and improvements to the first generation programs. These platforms include improved spcificty and delivery - including non-viral platforms, targeting of multiple antigens, editing constructs, and a variety of strategies to address toxicity and the tumor microenvironment. This panel of experts, moderated by Dr Gbola Amusa, Chardan and recorded at the 5th annual Immuno-Oncology 360° Summit, will consider the major technical and clinical improvements to cell based IO therapeutics that will lead to more durable therapies and the ability to treat both liquid and solid tumors. Panelists include: Dr Robert Ang, Neon TherapeuticsDr Usman "Oz" Azam, TmunityMichael Dombeck, Precision BioSciencesDr Aiman Shalabi, GSK Save the date for the 6th annual IO360° Summit on February 26-28, 2020 at the Crowne Plaza Times Square in New York City. Learn more at www.io360summit.com

Monetizing Science: Turning an Asset into Value through IPOs Oct 16, 2019

Show notes

This panel moderated by Dr Andrew Baum, Citi and recorded at the 5th annual IO360° Summit discusses the preparation of an IPO, straight licensing with the transition to a public company and decision making on prioritization within portfolios. Panelists include: David Epstein, Flagship PioneeringDan Passeri, Cue Biopharma Save the date for the 6th annual Immuno-Oncology 360° Summit on February 26-28, 2020 at the Crowne Plaza Times Square in New York City. Learn more at www.io360summit.com

IDO Changes the T-cell Balance in the Tumor Microenvironment Oct 16, 2019

Show notes

In this talk recorded at the 5th annual IO360° Summit, Dr Charles Link Jr, Newlink Genetics, addresses how IDO changes the T-cell balance in the tumor microenvironment. This talk addresses how: IDO creates local immunosuppression by increasing T regulatory cellsIDO often works in concert with PDL-1 mediated immunosuppressionIDO mediated T-cell immunosuppression leads to poor prognosis in melanoma Save the date for the 6th annual Immuno-Oncology 360° Summit on February 26-28, 2020 at the Crowne Plaza Times Square in New York City. Learn more at www.io360summit.com

Insights from Deal Trends: Betting on Tumor Immunology Aug 29, 2019

Show notes

In this podcast from the 2019 Immuno-Oncology 360° conference, Cello Health BioConsulting's EVP, Oncology Practice Head, Dr Jeff Bockman discusses deal-making and investments in the I-O space to see what can be learned about the expanding and shifting landscape of BioPharma and investor interest by examining who is placing what kinds of bets on which targets and modalities, at what stage and with what terms. Additional topics include: Where are the next big paradigm shifts going to be?Where is the next great target that will supersize foundational checkpoint therapy? Join us for the 6th annual IO360° conference on February 26-28, 2020 at the Crowne Plaza Times Square hotel in New York City. To learn more about the event, please visit IO360 2020.

Living with Alzheimer’s from a Young Patient's Perspective Aug 23, 2019

Show notes

Pharma Talk Radio producer, Valerie Bowling recently spoke with a young Alzheimer's patient, Jeff Borghoff. Jeff was officially diagnosed with Alzheimers in 2016 and is an active and patiionate patient advocate. Jeff generously shares his experience from diagnosis, to the experience of a clinical trial to his work in advocacy. Jeff will be speaking at the Patients as Partners conference on June 29-30, 2020 in Philadelphia. For more information, visit theconferenceforum.org We look forward to bringing you more podcasts featuring patient advocates and more on the topic of dementia. Resources that Jeff recommends: Alzherimer's AssociationAlzheimer's Congressional TeamAlzheimer's Association Early-Stage Advisory Group

Organizational and Digital Restructuring to Scale Mobile Clinical Trials Aug 23, 2019

Show notes

In this podcast from the 2018 Mobile in Clinical Trials conference, Mohammad Ali, Global Head Digital Trials- Global Clinical Operations, Boehringer-Ingelhiem and Joe Dustin, Principal, Mobile Health, Medidata Solutions discussed the internal infrastructure that is required for the successful scaling of mobile/digital tools in clinical trials. The discussion focuses on how to come to terms with the demand of data, understanding the skill set required to purposefully use the data and implementing an internal system to allow for efficient scaling of mobile trials.? Mohammad Ali is returning to Mobile 2019 to lead an interactive group activity on creating a pathway for brainstorming the digital biomarker process. Speakers: Mohammad Ali, Global Head Digital Trials- Global Clinical Operations, Boehringer-Ingelhiem Joe Dustin, Principal, Mobile Health, Medidata Solutions

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected